tiprankstipranks
Advertisement
Advertisement

CATX Stock Latest News

Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
Market NewsOptions Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
4d ago
DE
HD
Perspective Therapeutics doses first patients in two Phase 1/2a studies
PremiumThe Fly
Perspective Therapeutics doses first patients in two Phase 1/2a studies
4d ago
CATX
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
CATX
Perspective Therapeutics price target lowered to $6 from $7 at BofA
PremiumThe Fly
Perspective Therapeutics price target lowered to $6 from $7 at BofA
10d ago
CATX
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
PremiumThe Fly
Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)
10d ago
CATX
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
PremiumCompany AnnouncementsPerspective Therapeutics Highlights Q1 Progress and Strengthened Finances
11d ago
8K
CATX
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
Premium
Company Announcements
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
17d ago
8K
CATX
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
Premium
Company Announcements
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
1M ago
8K
CATX
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
PremiumThe Fly
Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET
1M ago
CATX
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
2M ago
8K
CATX
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
PremiumRatings
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
2M ago
CATX
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
PremiumThe Fly
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
2M ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
PremiumThe FlyPerspective Therapeutics price target raised to $8 from $7 at UBS
2M ago
CATX
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
Premium
The Fly
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
2M ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
Premium
The Fly
Perspective Therapeutics price target raised to $8 from $7 at UBS
2M ago
CATX
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
PremiumCompany Announcements
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
2M ago
8K
CATX
Perspective Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Perspective Therapeutics initiated with an Overweight at Piper Sandler
3M ago
CATX
Buy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside
PremiumRatings
Buy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside
3M ago
CATX
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline
PremiumCompany Announcements
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline
4M ago
8K
CATX
Midday Fly By: Disney slips despite Q1 beat, Devon to combine with Coterra
PremiumThe FlyMidday Fly By: Disney slips despite Q1 beat, Devon to combine with Coterra
4M ago
F
BAM
Perspective Therapeutics prices 39.58M shares at $3.79 in underwritten offering
Premium
The Fly
Perspective Therapeutics prices 39.58M shares at $3.79 in underwritten offering
4M ago
CATX
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
Premium
Company Announcements
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
4M ago
8K
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >